Literature DB >> 8692801

Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains.

R Murali1, P J Brennan, T Kieber-Emmons, M I Greene.   

Abstract

The epidermal growth factor receptor (EGFR) and p185c-neu proteins associate as dimers to create an efficient signaling assembly. Overexpression of these receptors together enhances their intrinsic kinase activity and concomitantly results in oncogenic cellular transformation. The ectodomain is able to stabilize the dimer, whereas the kinase domain mediates biological activity. Here we analyze potential interactions of the cytoplasmic kinase domains of the EGFR and p185c-neu tyrosine kinases by homology molecular modeling. This analysis indicates that kinase domains can associate as dimers and, based on intermolecular interaction calculations, that heterodimer formation is favored over homodimers. The study also predicts that the self-autophosphorylation sites located within the kinase domains are not likely to interfere with tyrosine kinase activity, but may regulate the selection of substrates, thereby modulating signal transduction. In addition, the models suggest that the kinase domains of EGFR and p185c-neu can undergo higher order aggregation such as the formation of tetramers. Formation of tetrameric complexes may explain some of the experimentally observed features of their ligand affinity and hetero-receptor internalization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692801      PMCID: PMC39008          DOI: 10.1073/pnas.93.13.6252

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.

Authors:  T Wada; X L Qian; M I Greene
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 3.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

4.  Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.

Authors:  D B Weiner; Y Kokai; T Wada; J A Cohen; W V Williams; M I Greene
Journal:  Oncogene       Date:  1989-10       Impact factor: 9.867

Review 5.  Signal transduction by allosteric receptor oligomerization.

Authors:  J Schlessinger
Journal:  Trends Biochem Sci       Date:  1988-11       Impact factor: 13.807

6.  Stage- and tissue-specific expression of the neu oncogene in rat development.

Authors:  Y Kokai; J A Cohen; J A Drebin; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.

Authors:  O Segatto; C R King; J H Pierce; P P Di Fiore; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

8.  C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells.

Authors:  S Mori; T Akiyama; Y Yamada; Y Morishita; I Sugawara; K Toyoshima; T Yamamoto
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

9.  Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.

Authors:  Y Kokai; J N Myers; T Wada; V I Brown; C M LeVea; J G Davis; K Dobashi; M I Greene
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

10.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Authors:  M F Press; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

View more
  17 in total

1.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.

Authors:  H T Zhang; J E Kacharmina; K Miyashiro; M I Greene; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Analysis of oligomeric proteins during unfolding by pH and temperature.

Authors:  Pradip Bhattacharya; Tamil Ganeshan; Soumiyadeep Nandi; Alok Srivastava; Prashant Singh; Mohommad Rehan; Reshmi Rashkush; Naidu Subbarao; Andrew Lynn
Journal:  J Mol Model       Date:  2009-02-11       Impact factor: 1.810

Review 4.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

5.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity.

Authors:  W Tsai; A D Morielli; E G Peralta
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

Review 6.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

7.  Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Authors:  Kaoru Kiguchi; Takuya Kitamura; Tricia Moore; Mohammad Rumi; Hsiang-Chun Chang; Devon Treece; Lynnsie Ruffino; Kevin Connolly; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-03

8.  Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Authors:  Benjamin C Ling; Jianqiang Wu; Shyra J Miller; Kelly R Monk; Rania Shamekh; Tilat A Rizvi; Gabrielle Decourten-Myers; Kristine S Vogel; Jeffrey E DeClue; Nancy Ratner
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

9.  c-erb-B2 expression and response to treatment in metastatic breast cancer.

Authors:  W R Bezwoda
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

10.  Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.

Authors:  Toru Kumagai; Makoto Katsumata; Akihiro Hasegawa; Keiji Furuuchi; Toshiki Funakoshi; Ichiro Kawase; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.